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Abstract 
The role of the calcitriol / vitamin D receptor (VD) endocrine system and the 
pleiotropic effects of this system in the pathogenetic mechanisms of various diseases 
development, in particular complications of pregnancy, has attracted researches’ increasing 
attention in recent years. 
The aim of the work: to compare the VD-status and frequency of occurrence of 
polymorphism of the VDR gene (BsmI (A> G, rs1544410) in patients with a physiological 
course of the gestation process and in patients with placental dysfunction (PD). 
Materials and methods. 56 pregnant women with PD (the main group) and 40 
patients with a physiological pregnancy (control group) were examined. 
VD status was determined by ELISA at level 25 (OH) D in serum, the frequency of 
BsmI polymorphism of the VDR gene (rs1544410) by polymerase chain reaction (PCR). 
Results. The average index of VD (31.40 ± 8.6) ng / ml in patients with PD is 
significantly lower than in patients with physiological pregnancy (43.54 ± 11.20) ng / ml,  
(p ≤ 0.05 ). 
In patients with PD, homozygous carrier for the A-allele was found in 12% of cases, 
in healthy pregnant women - in 16.7%, (р ≥ 0.05), for the G-allele - in 20% and 47.20%,  
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(р ≤ 0.01) cases, respectively to groups. Heterozygous combination of A / G alleles was noted 
in 68% of patients with PD and in 36.10% of the control group patients. In pregnant women 
with BsmI polymorphism of calcitriol gene (genotype A / G) PD was 3.7 times more frequent 
(68% vs 36.10% : RR = 2.1, CI 1.0-6.6, OR = 3.7, CI 1.1-13.1). 
Conclusions. Vitamin D insufficiency or deficiency can be one of the reasons of PD 
formation. In carriers of BsmIgene’s polymorphism encoding VD receptor with genotype A / 
G, the course of pregnancy is complicated by placental dysfunction 3.7 times more often than 
in women without this polymorphism. 
Key words: vitamin D, polymorphism of VDR gene, placental dysfunction. 
 
Introduction. Recent years studies have shown that the endocrine system of vitamin 
D (VD) / vitamin D receptors (VDR) and the extra-skeletal pleiotropic effects of this system 
have an important role in the women’s reproductive function. The effect on reproductive 
function is due to the presence of VDR in endometrial cells, myometrium, ovarian tissue, in 
the vascular endothelium, in trophoblast cells and in placenta [2, 3, 4]. 
Calcitriol’s main way of action is the genomic mechanism. Calcitriol-activated VDRs 
related to the family of nuclear steroids create (RXR) heterodimer with nuclear retinoid X-
receptors, which, in its turn, binds to DNA elements and modulates the transcription of certain 
genes [5, 7, 12]. In addition, there is an extra-genomic, rapid pathway of calcitriolinfluence, 
when the latter binds to VD receptors of cytoplasmic membrane caveols and triggers one or 
more signaling cascades, including activation of protein kinase C, mitogen-activated protein 
kinases, phospholipases A2 and phospholipases C [5, 12]. 
The prevalence of VDR in cells and organs of the reproductive system served as the 
basis for carrying out studies of the VDR gene polymorphism in patients with pathological 
course of the gestational process [8, 9]. 
It is known that changes in the nucleotide sequence of DNA that occur in a population 
with a frequency of more than 1% are considered genetic polymorphism. VDR is encoded by 
a gene located in chromosome 12q12-14 [6]. Currently, there are four known single 
nucleotide polymorphisms (SNP-singlenucleotidepolymorphism) of VDR gene. Two of them 
are in exons - FokI (C> T, rs10735810) and TaqI (T> C, rs731236), the others are located in 
the last intron - BsmI (A> G, rs1544410) and ApaI (A> C, rs7975232) [3, 6.9]. 
The aim. To make a comparative evaluation of vitamin D status and frequency of 
occurrence of polymorphism of VDR gene (BsmI (A> G, rs1544410) in patients with 
physiological course of the gestation process and in patients with PD. 
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Materials and methods. 56 pregnant women with PD (primary, group I) and 40 
patients with a physiological course of pregnancy (control group, group II) were examined. 
The average age of patients in the main group was 29.21 ± 4.3 years, in the control 
group - 30.35 ± 3.12 years (t = 1.53, p> 0.05). 
Anthropometric data on the patients under examination showed signs of homogeneity 
of groups: body mass index (BMI) in patients of the main group corresponded to (22.2 ± 1.7) 
conventional units (cu), and in the control group - (22.8 ± 1.93) у.е ., (t = 0.7, p> 0.05). 
In the main group 71.43% of the patients were primiparous, in the control group – 
55.00%; (p <0.05), multiply (2nd and 3rd genera) - 28.57% and 45.00%, respectively, to 
groups (p <0.05). 
It was found that 21.43% of  the main group patients had a history of infertility about 
2-4 years, whereas in the control group this indicator was 10%, which is 2.1 times less  
(F = 0.049, p <0.05 , χ2 = 2.19, p> 0.05). In addition, 28.57% of the women in the primary 
group and 2.50% in the control group reported miscarriage, (F = 0.0008; p <0.05; χ2 = 10.88; 
p <0.01). 
In 26.79% and in 5.00% of pregnant women of the main and control groups, cervical 
cancer was diagnosed, (F = 0.0003, p <0.05, χ 2 = 7.6, p <0.01). Also, 10.71% of the patients 
in the main group had uterine fibroids, in the control group there were no such patients,  
(F = 0.002; p <0.05; χ2 = 4.57; p <0.05). 
All pregnant women have undergone general clinical examination, stipulated by the 
order of the Ministry of Health of Ukrainedated July 15, 2011, N 417 "On the organization of 
outpatient obstetric and gynecological care in Ukraine." Patients from the risk group for the 
implementation of intrauterine infection were examined in accordance with the order of the 
Ministry of Health of Ukraine dated December 27, 2006, N 906 "Perinatal infections" All the 
patients gave informed consent for the surveys. 
To assess the functional state of the feto-placental complex, an ultrasound examination 
was used to assess the fetometric data of the intrauterine fetus and the Doppler blood flow 
assessment in accordance with the pregnancy schedule indicated in the clinical protocols and / 
or according to the indications. The cardiotocography (CTG), biophysical profile of the fetus, 
and the actographic tests were evaluated. 
Ultrasound was performed on the Samsung Medison UGEO WS80A (Samsung 
Medison CO, LTD, 2014, Korea), CTG - on the Sonicaid Team Care fetal monitor (Huntleigh 
HEALTHCARE, LTD, 2006, UK), which provides for automatic transcription the obtained 
curve with an STV rating (short term arability); the data of the CTG were evaluated using the 
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Fisher’s scale. 
The status of vitamin D was determined by enzyme immunoassay (ELISA) method at 
level 25 (OH) D in serum, which is the main circulating metabolite of VD and can be 
quantified. 
Polymerase chain reaction (PCR) with real-time detection of the results and analysis of 
melting curves was used to evaluate the frequency of BsmI polymorphism of VDR gene 
(rs1544410). DNA was isolated using a set of reagents "probe-Rapid Genetics", ("DNA-
technology", Russia). For PCR diagnostics a detection of inhibitor DT-96, (LLC "NPO DNA-
Technology", Russia) was used. 
Blood sampling from the ulnar vein for special studies was performed on an empty 
stomach: for EIA - in mono-light, for genotyping - in vacuum tubes Vacuette by 4 ml with the 
addition of anticoagulant (disodium salt - ethylene diamine-tetraacetate - EDTA). 
Verification of perinatal infection was carried out by ELISA and PCR. In the detection 
of specific immunoglobulins (Ig) in the blood of pregnant women in a diagnostically 
significant titer, a second study of "paired sera" was conducted to determine the avidity and 
affinity of antibodies. 
All special studies on the definition of vitamin D-status were carried out in the 
diagnosis of PD in the 2nd and 3rd trimester of pregnancy, which was the basis for the 
isolation of groups I-A and I-B: 22 patients (39.29%) of the main group (group I-A ) were 
examined in the 2nd trimester of pregnancy, 34 patients (60.71%) - in the 3rd trimester (group 
I-B). 
Statistical processing of the data obtained was carried out with the help of Biostat 6.0. 
Results and discussion. 
The course of pregnancy in the examined women was characterized by some features. 
Thus, the proportion of patients who had recurred ARI during pregnancy in the main group 
was 30.36% compared to 7.5% of the control group, (F = 0.0004; p <0.05; χ 2 = 7.39;  
p <0.01). 
The frequency of bacterial vaginosis in the main group of pregnant women was 
32.14% compared to 7.5% in the group of healthy pregnant women, (F = 0.0008; p <0.05;  
χ2 = 8.29; p <0.01). Also in 64.29% (5 times more often) of the women from the main group 
and 12.5% in the control group, colpuli of mixed etiology were diagnosed, (F = 0.0001;  
p <0.05; χ2 = 25.57; p <0.01). It should be noted that in 37.50% of the main group women 
there was an exacerbation of chronic pyelonephritis, in the control group of such patients it 
was 2.5 times less - 15.00%, (F = 0.0006; p <0.05; χ 2 = 5.84, p <0.05). 
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Pregnancy was complicated by gestational anemia in 50.00% of women in the PD 
group and only 10% in those without violations of PD, (F = 0.00001 p <0.05, χ 2 = 12.19  
p <0.01) . 
The threat of miscarriage in patients with PD was diagnosed 7.5 times more often than 
in the control group: 75.00% vs. 10.00%, (F = 0.0001, p <0.05, χ 2 = 39, 50; p <0.01). In 
addition, in 14.29% of women with PD, the course of pregnancy was complicated by 
preeclampsia, in the control group the cases of preeclampsia were not noted, (F = 0.0007;  
p <0.05; χ 2 = 6.23; p <0.05). 
When assessing VD status of the patients, it was established that the mean level of 
blood VD in patients with PD was significantly lower (31.40 ± 8.6) ng / ml than in the 
patients with physiological pregnancy (43.54 ± 11,20) ng / ml, (p ≤ 0.05), (Figure 1). 
. 
 
 
Fig. 1. Vitamin D-status in women with a physiological course of the gestation process 
and in pregnant women with placental dysfunction. 
 
In accordance with the guidelines for the treatment and prevention of VD deficiency 
for the population of central Europe, (Pludovsky P., Povoroznyuk V., et al., 2013), serum VD 
levels below 20 ng / ml indicate a deficiency of the latter, 20-30 ng / ml - about suboptimal 
status, which requires its daily dose increase. For adequate or optimal VD status, its content 
should be above 30-ng / ml. 
According to our data, the average level of vitamin D in a group of patients with PD 
corresponds to a suboptimal status, which, probably, may not be sufficient to adequately 
support the mother's body and the growing intrauterine fetus. 
It should be noted that VD deficiency status in the main group was diagnosed in every 
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third patient (28.60%), which was 1.9 times more than in the group of women with 
physiological pregnancy, where there were only 15.30% , (RR = 1.42, CI95% -1.08-1.87,  
p ≤ 0.05), (Figure 2). 
 
 
Fig. 2. Proportion of patients with vitamin D deficiency status in the group of pregnant 
women with PD and with the physiological course of pregnancy. 
 
Taking into consideration the data of literature on the pleiotropic effects of vitamin D, 
in particular its role in regulating angiogenesis [13], invasion of trophoblast [14], implantation 
[15], it can be assumed that the suboptimal level of calcitriol in the blood of pregnant women 
does not adequately respond to the needs of a pregnant woman and can lead to an imbalance 
in adaptation-compensatory mechanisms aimed at the formation and functional formation of 
the utero-placental-fetal circle of the circulation. 
In support of this assumption, data on the interaction of the calcitriol with the L-
arginine-nitric oxide bioregulatory system, which in its turn plays one of the leading roles in 
the formation of endothelial dysfunction and in the genesis of the formation of various 
pathologies in the microcirculatory bed [16, 17, 18]. In this situation the utero-placental-fetal 
circle of blood circulation can be a target for the realization of the negative consequences of 
vitamin D deficiency. 
When assessing the frequency of different genotypes and alleles of the BsmI 
polymorphism (rs1544410) of VD receptor gene, the following data were obtained in the 
patients of the groups under examination. 
The polymorphism of the gene encoding VDR in the allele type AA in the main 
(12.00%) and control (16.70%) groups did not have a significant difference, (p ≥ 0.05), which 
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suggested that this variant of the genotype did not exert any influence on the formation of PD 
dysfunction. 
In abnormal pregnancy patients, homozygous carriage with GG-allele was observed in 
20% of cases, which is 2.4 times less than in the group of patients without placental 
dysfunction, where this index was 47.20% (p ≤ 0.01). 
Heterozygous combination of A / G alleles was noted in 68% of PD pregnant women, 
and in the group of healthy pregnant women it was 36.10% (p <0.01, CI 95%), (Fig. 3). 
 
 
Fig. 3. Distribution of allelic variants of VDR gene in accordance with BsmI 
polymorphism in PD patients and in pregnant women with physiological pregnancy. 
 
The data obtained allow to suggest that VDR gene polymorphism in the heterozygous 
variant of allele A / G, which is characteristic of 68% of the patients in the main group, may 
be a significant factor in complicating the gestational process by PD, whereas the 
homozygous combination of the G / G allele revealed in a half (47.20 %) of healthy pregnant 
women, can have a certain protective effect. The prevalence of the allelic combination of  
A / A in the groups did not have significant differences. 
In pregnant women with BsmI polymorphism of  gene encoding vitamin D receptor, in 
the presence of the A / G genotype, PD was observed 3.7 times more often (68% vs 36.10%: 
RR = 2.1, CI95% - 1.0-6, 6, OC = 3.7, CI 1.1-13.1), which may indicate a significant  
contribution of this variant of allelic genes to the development of PD. 
The risk of a possible complication of pregnancy by PD in pregnant with A / G allelic 
VDR genes is 4 times higher than in patients with other variants of genotypes. 
Results of the statistical correlation analysis and calculations of the relative risk of 
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formation of PD allowed to determine the odds ratio (OR, J. Cornfield, 1951) and to assess 
the degree of dependence of the revealed disorders with the patient's genotype (Table 1). 
 
Table 1 
The frequency of genotypes and alleles of BsmI polymorphism of the vitamin D receptor 
gene inpregnant women with PD and in healthy pregnant women 
Genotypes 
& alleles, 
% 
PD- 
group 
PD-free 
group 
OR RR χ2 P 
G/G 20% 47.20% 0.27;CI 
0.15-0.5 
0.40; CI 
0.33 -0.72 
16.71 P<0.01 
A/G 68% 36.10% 3.78; CI 
2.1 - 6.8 
1.96; CI 
1.43-2.69 
20.88 P<0.01 
A/A 12% 16.70% 0.67; CI 
0.3-1.48 
0.8; CI 
0.5-1.27 
1.013 P>0.05 
A 46% 34.75% 1.58; CI 
0.89-2.79 
1/25; CI 
0.95-1.65 
2.51 P>0.05 
G 54% 65.25% 0.63; CI 
0.36-1.12 
0/80; CI 
0.61-1.05 
7.30 P<0.01 
 
It has been established that there is a direct relationship between the average force 
between placental dysfunction and the genotype of A / G calcitriol’sreceptors at 95% DIL, 
(RR = 1.96, CI 1.43-2.69, OR = 3.8, CI 2.1-6 , 8, χ2 = 20.88, p <0.01). 
The revealed feedback of the mean force between this genotype and placental 
dysfunction (OR = 0.27, CI 0.15-0.5, RR = 0.40, CI 0.33-0, 72; χ2 = 16,716; p <0.01) testifies 
in favor of the protective value of the genotype G / G. 
The risk of PD development in patients with the G / G genotype is significantly less 
(less than 1-0.27, 95% CI). In the group of pregnant women with a physiological course of 
gestation there are 47.20% of such women, while in the main group they are only 20%. 
The frequency of allele A in the group of patients with PD was 46%, in the group of 
healthy pregnant women - 34.75%, (p> 0.05); and the allele G, respectively, 54% and 
65.25%, (p <0.01), which also suggests the protective value of the G allele. 
The Pearson criterion index (G / G-χ2 = 16.71, A / G-χ2 = 20.88) confirms the 
existence of significant differences between the frequencies of distribution of A / G genotypes 
in G / G in the compared groups and the dependence of PD incidence on BsmI polymorphism 
of the gene encoding the vitamin D receptor is statistically significant: patients with the A / G 
genotype can be attributed to the risk group for the development of PD. 
Conclusions. Thus, a comparative evaluation of vitamin D-status and the frequency of 
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occurrence of polymorphism of VD receptor gene (BsmI (A> G, rs1544410) in patients with a 
physiological course of the gestation process and in patients with PDallows for the number of 
conclusions. 
In pregnancy, complicated by PD, the level of vitamin D (25 (OH) D) in the blood 
serum is significantly lower than in pregnant women with a physiological course of the 
gestational process (31.4 ng / ml versus 43.5 ng / ml, (p <0 , 05). 
The proportion of patients with VD deficiency and suboptimal vitamin D level in the 
blood in the group of women with PD is 1.86 times more than in the group with a 
physiological pregnancy (28.5% VS 15.3%, RR = 1.42; CI 95%). 
In carriers of BsmI polymorphism of the gene encoding VD receptor, in the presence 
of the genotype A / G, pregnancy is complicated by PD 3.6 times more often than in this 
polymorphism-free women. 
The risk of formation of PD is minimal (OR = 0.27) in homozygous women with 
genotype G / G of VD receptor, which can, with a high probability, attest to the protective 
role of this genotype and the absence of predisposition to complicating pregnancy with 
impaired PD. 
The data obtained indicate the necessity for further studies to determine the 
importance of vitamin D status during the gestational process and the formation of various 
complications of pregnancy. 
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